Quarters Trustees Ltd & Susan Beaumont

Findings — machine-extracted (anthropic-batch:claude-opus-4-8); verify against the decision

The First Respondent solicitor, the Second Respondent (recognised body) and the Third Respondent (former RFL) admitted numerous breaches of the Solicitors Accounts Rules and Solicitors Code of Conduct relating to a shambolic accounting system, improper transfers of client money without consent, and improper billing practices affecting pension trust funds. Two dishonesty allegations (falsifying documents and dishonestly overcharging) were withdrawn with Tribunal permission, and no dishonesty was found. Matter resolved by a Memorandum of Agreed Terms. The First Respondent was struck off the Roll (undertaking never to reapply); the Tribunal noted his conduct was so serious that striking off was warranted even without dishonesty, and no fine was imposed given his bankruptcy. The Second Respondent's recognition was revoked and the Third Respondent was prohibited from re-registration as an RFL. All three were jointly and severally liable for costs of £93,623.13 inclusive of VAT.

Duties found breached:

• No improper communication with the court
• No conflict between current clients
• Handle inadvertently received material
• No improper use of client money
• Report serious misconduct of others

Aggravating factors:

• Very large sums involved (stated as £50m to £160m administered or held in trust)
• Problems persisted over an extended period despite clear warnings
• Two qualified Accountants' Reports (2006 and 2007) with no improvement made
• Cavalier and wholesale disregard of the SAR
• Account structure created opportunity for misappropriation
• Suspicion that clients had been overcharged

Mitigating factors:

• Distinguished prior career in pensions law at Nabarro Nathanson
• Founded and chaired the Association of Pension Lawyers
• Unblemished record prior to these matters
• Placed trust in employees who proved unworthy
• Accepted responsibility ('the buck stopped with him')
• Overwhelmed by multiple concurrent regulatory investigations